A Single-Arm Phase Ⅱ Study of Fluzoparib Maintenance in Platinum-sensitive Advanced Triple-Negative Breast Cance

Clinical trial NCT07321015 · RECRUITING

Trial details

NCT number: NCT07321015
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Platinum-sensitive TNBC, Triple Negative Breast Cancer BRCA1/2 Mutation or Not

Start date: 2026-01-20
Primary completion: 2027-11-30
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.